Avadel Pharmaceuticals PLC is a specialty pharmaceutical company engaged in identifying, developing, and commercializing niche branded pharmaceutical products. The Company develops differentiated products through the application of the Company’s proprietary patented drug delivery platforms, Micropump and LiquiTime. In addition to Micropump and LiquiTime, the Company has two other proprietary drug delivery platforms, Medusa (hydrogel depot technology for use with large molecules and peptides) and Trigger Lock (controlled release of opioid analgesics with potential abuse deterrent properties). Avadel Pharmaceuticals is also engaged in the identification of Unapproved Marketed Drugs (“UMDs”) and the acquisition of commercial and or late-stage products or businesses.